Presence of maternal antibodies to human immunodeficiency virus 1 envelope glycoprotein gp120 epitopes correlates with the uninfected status of children born to seropositive mothers.
about
Increased immune response elicited by DNA vaccination with a synthetic gp120 sequence with optimized codon usageA large array of human monoclonal antibodies to type 1 human immunodeficiency virus from combinatorial libraries of asymptomatic seropositive individualsVertical transmission of human immunodeficiency virus (HIV) infection. Reactivity of maternal sera with glycoprotein 120 and 41 peptides from HIV type 1Pathogenesis of human immunodeficiency virus infectionMaternal plasma viral load and neutralizing/enhancing antibodies in vertical transmission of HIV: a non-randomized prospective studyImmunoprophylaxis against mother-to-child transmission of HIV-1Vertical transmission of human immunodeficiency virus is correlated with the absence of high-affinity/avidity maternal antibodies to the gp120 principal neutralizing domain.Frequent detection of escape from cytotoxic T-lymphocyte recognition in perinatal human immunodeficiency virus (HIV) type 1 transmission: the ariel project for the prevention of transmission of HIV from mother to infant.Influence of carbohydrate moieties on the immunogenicity of human immunodeficiency virus type 1 recombinant gp160.Impact of the placental cytokine-chemokine balance on regulation of cell-cell contact-induced human immunodeficiency virus type 1 translocation across a trophoblastic barrier in vitro.Conservation of an intact vif gene of human immunodeficiency virus type 1 during maternal-fetal transmission.Production of site-selected neutralizing human monoclonal antibodies against the third variable domain of the human immunodeficiency virus type 1 envelope glycoprotein.Persistence of multiple maternal genotypes of human immunodeficiency virus type I in infants infected by vertical transmission.Safety and efficacy of HIV hyperimmune globulin for prevention of mother-to-child HIV transmission in HIV-1-infected pregnant women and their infants in Kampala, Uganda (HIVIGLOB/NVP STUDY).Antibodies for prevention of mother-to-child transmission of HIV-1HIV-I infection in perinatally exposed siblings and twins. The Italian Register for HIV Infection in Children.Genetic analysis of human immunodeficiency virus type 1 envelope V3 region isolates from mothers and infants after perinatal transmission.Analysis of envelope sequence variants suggests multiple mechanisms of mother-to-child transmission of human immunodeficiency virus type 1Leukemia inhibitory factor inhibits HIV-1 replication and is upregulated in placentae from nontransmitting women.The vertical transmission of human immunodeficiency virus type 1: molecular and biological properties of the virus.Maternal HIV-1 envelope-specific antibody responses and reduced risk of perinatal transmission.Human cord blood mononuclear cells are preferentially infected by non-syncytium-inducing, macrophage-tropic human immunodeficiency virus type 1 isolates.Independent variation and positive selection in env V1 and V2 domains within maternal-infant strains of human immunodeficiency virus type 1 in vivoPoliovirus chimeras expressing sequences from the principal neutralization domain of human immunodeficiency virus type 1.HIV-neutralizing antibodies: epitope identification and significance for future vaccine.Comparison of antibody reactivity to human immunodeficiency virus type 1 (HIV-1) gp160 epitopes in sera from HIV-1-infected individuals from Tanzania and from the United States.Genetic risk factors for perinatally acquired HIV-1 infection.Women and AIDS.Examination of sera from human immunodeficiency virus type 1 (HIV-1)-infected individuals for antibodies reactive with peptides corresponding to the principal neutralizing determinant of HIV-1 gp120 and for in vitro neutralizing activity.Maternal Binding and Neutralizing IgG Responses Targeting the C-Terminal Region of the V3 Loop Are Predictive of Reduced Peripartum HIV-1 Transmission RiskMother-to-infant HIV transmission: timing, risk factors and prevention.Prospects for prevention of vertical transmission of human immunodeficiency virus by immunization.Informed consent to HIV antibody testing.Human immunodeficiency virus type 1 mother-to-child transmission and prevention: successes and controversies.Maternal HIV-1 Env Vaccination for Systemic and Breast Milk Immunity To Prevent Oral SHIV Acquisition in Infant Macaques.
P2860
Q24531468-D4E1C8D5-90E2-42BB-83AC-E6E3CF07DF63Q24560010-B86680C0-03F8-4775-9E47-8F86208041DFQ24628991-73C97F47-90D5-4CAB-9369-AD4B137A38BEQ24634681-D1CFB19D-9490-4AC4-B4A3-6017606A32B7Q24804378-FE1084BF-43F4-4706-92DA-D98E34415360Q33250208-25ACA588-C985-4AB9-9B2D-CAE5F7E4D5F9Q33564746-4C1B8CE4-A078-4343-8969-A756A92C8A65Q33647187-AAA764F8-B3E4-42ED-A236-4378BC30B6FEQ33933098-6E7B5EE2-DA8B-4685-9A3A-666ADC3BAA1EQ33984163-B8BF490F-0D26-4864-A87A-33B8190A640AQ34069296-885151FC-EB6C-41D0-8AD9-63FC20F73569Q34097650-A2A5FF07-762C-49D1-ADC8-502BAD1A4D68Q34121239-A40B9F29-BA4C-4D75-AA69-6A770DD39300Q35475930-8CEBD083-52E2-49B6-9828-5956F3DC6866Q35619402-47C542D0-7CDB-48B0-B8F8-4B8DB0D537EAQ35627501-25A7BFBB-4BBD-48CF-9EAE-57F726C1DB23Q35832182-0A97E141-F855-467A-B7F5-953FB5A0F23BQ35839969-554E7901-9694-479F-BF7F-9E691DA3391FQ36010728-ECF602E0-2857-4F0A-BBA8-F39C795F803BQ36033283-8025B756-BC6B-40BB-A421-90CC39FBCB52Q36184762-E009800C-52C1-4EE6-A57D-C5C854777182Q36518135-D7310E8B-7EDF-49CB-A4B9-8C1B749EDC83Q36649929-7F44DF1F-0BE4-429B-BB6C-091091E797DCQ36697629-B5B3359F-F86E-4908-8A82-2B40E39681FDQ36708990-C52E5DD9-3285-4802-8971-04CD5161B28BQ37114616-1814A821-5DA4-47A2-9A81-4C649C7B70BCQ39239480-43B0F07C-121C-4F0C-84B3-15DD01F028AFQ39440269-A839A5AF-C175-4714-83AC-46DCFBB63EF1Q39579497-5C62E125-DCB3-451F-9D10-359C152EA10CQ40331385-22A586F4-E44A-4D8D-A1A8-71C466E9740AQ40510235-C4AA0D8A-2903-4437-AC39-DD92690A36CAQ40793604-768F2612-919B-4F51-8261-AD4674178D54Q43165907-C0331975-3A57-48F7-8AB0-1A47F7616C1FQ45363198-A1936786-483D-4049-88A9-C082EB47931DQ47550072-C9E9542A-77F0-479F-A46C-F3664D3ECFFC
P2860
Presence of maternal antibodies to human immunodeficiency virus 1 envelope glycoprotein gp120 epitopes correlates with the uninfected status of children born to seropositive mothers.
description
1989 nî lūn-bûn
@nan
1989 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1989 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1989年の論文
@ja
1989年論文
@yue
1989年論文
@zh-hant
1989年論文
@zh-hk
1989年論文
@zh-mo
1989年論文
@zh-tw
1989年论文
@wuu
name
Presence of maternal antibodie ...... born to seropositive mothers.
@ast
Presence of maternal antibodie ...... born to seropositive mothers.
@en
Presence of maternal antibodie ...... born to seropositive mothers.
@nl
type
label
Presence of maternal antibodie ...... born to seropositive mothers.
@ast
Presence of maternal antibodie ...... born to seropositive mothers.
@en
Presence of maternal antibodie ...... born to seropositive mothers.
@nl
prefLabel
Presence of maternal antibodie ...... born to seropositive mothers.
@ast
Presence of maternal antibodie ...... born to seropositive mothers.
@en
Presence of maternal antibodie ...... born to seropositive mothers.
@nl
P2093
P2860
P356
P1476
Presence of maternal antibodie ...... born to seropositive mothers.
@en
P2093
Broliden PA
Giaquinto C
Ljunggren K
Moschese V
P2860
P304
P356
10.1073/PNAS.86.20.8055
P407
P577
1989-10-01T00:00:00Z